146 related articles for article (PubMed ID: 3328030)
1. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Leder GH; Fiebig HH; Wallbrecher E; Winterhalter BR; Löhr GW
Lipids; 1987 Nov; 22(11):958-61. PubMed ID: 3444393
[TBL] [Abstract][Full Text] [Related]
4. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Fromm M; Berdel WE; Schick HD; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):916-8. PubMed ID: 3444385
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic cell inhibition with new ether lipid analogs.
Noseda A; Berens ME; Piantadosi C; Modest EJ
Lipids; 1987 Nov; 22(11):878-83. PubMed ID: 3444381
[TBL] [Abstract][Full Text] [Related]
7. Ether lipids and derivatives as investigational anticancer drugs. A brief review.
Berdel WE
Onkologie; 1990 Aug; 13(4):245-50. PubMed ID: 2234777
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2.
Andreesen R; Giese V
Lipids; 1987 Nov; 22(11):836-41. PubMed ID: 3502166
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
[TBL] [Abstract][Full Text] [Related]
11. Ether lipids in cancer chemotherapy.
Berdel WE; Okamoto S
Keio J Med; 1990 Jun; 39(2):75-8. PubMed ID: 2214502
[TBL] [Abstract][Full Text] [Related]
12. Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
Berdel WE; Von Hoff DD; Unger C; Schick HD; Fink U; Reichert A; Eibl H; Rastetter J
Lipids; 1986 Apr; 21(4):301-4. PubMed ID: 3713449
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antineoplastic properties of ether-linked thioglycolipids.
Guivisdalsky PN; Bittman R; Smith Z; Blank ML; Snyder F; Howard S; Salari H
J Med Chem; 1990 Sep; 33(9):2614-21. PubMed ID: 2391700
[TBL] [Abstract][Full Text] [Related]
14. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
Storch J; Munder PG
Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
[TBL] [Abstract][Full Text] [Related]
15. Comparison of selective cytotoxicity of alkyl lysophospholipids.
Vogler WR; Olson AC; Okamoto S; Shoji M; Raynor RL; Kuo JF; Berdel WE; Eibl H; Hajdu J; Nomura H
Lipids; 1991 Dec; 26(12):1418-23. PubMed ID: 1819744
[TBL] [Abstract][Full Text] [Related]
16. A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C.
van Blitterswijk WJ; van der Bend RL; Kramer IM; Verhoeven AJ; Hilkmann H; de Widt J
Lipids; 1987 Nov; 22(11):842-6. PubMed ID: 3444375
[TBL] [Abstract][Full Text] [Related]
17. Ether lipids in the therapy of cancer.
Andreesen R
Prog Biochem Pharmacol; 1988; 22():118-31. PubMed ID: 3043427
[No Abstract] [Full Text] [Related]
18. Antitumor activity of synthetic alkylphospholipids with or without PAF activity.
Kudo I; Nojima S; Chang HW; Yanoshita R; Hayashi H; Kondo E; Nomura H; Inoue K
Lipids; 1987 Nov; 22(11):862-7. PubMed ID: 3444379
[TBL] [Abstract][Full Text] [Related]
19. Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells.
Berkovic D; Gründel O; Berkovic K; Wildfang I; Hess CF; Schmoll HJ
Radiother Oncol; 1997 Jun; 43(3):293-301. PubMed ID: 9215791
[TBL] [Abstract][Full Text] [Related]
20. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
